Glassman Wealth Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-21
Closed -$6.44K 1139
2023
Q4
$6.44K Buy
21
+19
+950% +$5.13K ﹤0.01% 1004
2023
Q3
$484 Hold
2
﹤0.01% 1740
2023
Q2
$480 Hold
2
﹤0.01% 1646
2023
Q1
$376 Hold
2
﹤0.01% 1668
2022
Q4
$425 Hold
2
﹤0.01% 1659
2022
Q3
$0 Hold
2
﹤0.01% 1864
2022
Q2
$0 Sell
2
-7
-78% -$1.01K ﹤0.01% 1872
2022
Q1
$1K Buy
+9
New +$1.48K ﹤0.01% 1447
2021
Q1
Sell
-114
Closed -$16K 1545
2020
Q4
$16K Hold
114
﹤0.01% 593
2020
Q3
$13K Buy
+114
New +$13.2K ﹤0.01% 548
2019
Q4
Sell
-3
Closed 1356
2019
Q3
$0 Buy
+3
New +$227 ﹤0.01% 1240

Other funds holding MEDP

Glassman Wealth Services's MEDP Position: Q1 2024 in Review

Glassman Wealth Services sold out of Medpace (MEDP) in Q1 2024, closing a stake of 21 shares — an estimated $6.44K sold.

Glassman Wealth Services first reported a position in MEDP in Q3 2019 and held it in 11 quarters. The position peaked at $16K in Q4 2020. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

  • Glassman Wealth Services reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 21 Medpace shares in Q1 2024, an estimated $6.44K.
  • Glassman Wealth Services first reported a position in Medpace in Q3 2019 and held it in 11 quarters.
  • Glassman Wealth Services's Medpace position peaked at $16K in Q4 2020.
  • 597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.